Fridha Viridiana Villalpando-Vargas, Juan José Rivera-Valdés, Anabell Alvarado-Navarro, Selene Guadalupe Huerta-Olvera, José Macías-Barragán, Erika Martínez-López, Omar Graciano-Machuca
Journal: Inflammation research : official journal of the European Histamine Research Society ... [et al.] 2022;70(10-12):1201-1210
PMID: 34705056
BACKGROUND
Psoriasis (Ps) is a chronic dermatosis characterized by erythematous-squamous plaques derived from an inflammatory response. The effect of polymorphisms in the genes that encode the members of the IL-17 family and their receptors has been studied to find an association with the susceptibility to Ps. However, the findings have not been conclusive.
OBJECTIVES
To describe the association between IL-17A, IL-17F and IL-17RA gene polymorphisms and susceptibility to Ps.
METHOD
A systematic review was conducted using the PubMed and Scopus databases to identify studies that evaluated the association between IL-17A, IL-17F, and IL-17RA gene polymorphisms and Ps susceptibility. This meta-analysis included reports published until June 2021. Heterogeneity was assessed using Cochran's Q-statistic test and I statistics. The associations between polymorphisms and Ps susceptibility were determined by pooled OR with a 95% CI.
RESULTS
Fifteen studies were included. The frequency of the T allele of the IL-17F rs763780 polymorphism was significantly lower in patients with vulgar Ps (OR = 0.732, p = 0.026). The TT genotype of the IL-17F rs763780 polymorphism was significantly associated with a decreased frequency in individuals with Ps and psoriatic arthritis (PsA) (TT:TC + CC OR = 0.664, p = 0.046). Regarding IL-17RA polymorphisms, the AG genotype of the rs4819554 polymorphism showed a near-significant decrease in psoriasis risk compared to the GG genotype (AG:GG OR = 0.604, p = 0.050). Other polymorphisms in IL-17A, IL-17F and IL-17RA showed no association with Ps.
CONCLUSIONS
The T allele and TT genotype of the IL-17F rs763780 polymorphism may be associated with a decreased risk of psoriasis. Therefore, the implications of this variant on psoriasis pathogenesis and treatment require further investigation.
© 2021. The Author(s), under exclusive licence to Springer Nature Switzerland AG.
Medical:
Miscellaneous:
Research Materials:
Full Text Sources:
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.